We are live on ! Find out more
TTOO

T2 Biosystems, Inc
TTOO

Delisted

TTOO was delisted on the 11th of February, 2025.

Back to rankings

70 hedge funds and large institutions have $9.92M invested in T2 Biosystems, Inc in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more call options, than puts

Call options by funds: $280K | Put options by funds: $177K

36% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 11

4% less funds holding

Funds holding: 73 → 70 (-3)

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

53% less capital invested

Capital invested by funds: $21.1M → $9.92M (-$11.2M)

Holders
70
Holders Change
-3
Holders Change %
-4.11%
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
15
Reduced
11
Closed
12
Calls
$280K
Puts
$177K
Net Calls
+$103K
Net Calls Change
+$12K

Top Buyers

Rank Fund Capital Flow
1
GS
Gagnon Securities
New York
+$170K
2
VF
Virtu Financial
New York
+$136K
3
Citadel Advisors
Citadel Advisors
Florida
+$108K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$104K
5
Jane Street
Jane Street
New York
+$62.6K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$1.74M
2
Millennium Management
Millennium Management
New York
-$497K
3
N
Natixis
France
-$491K
4
Principal Financial Group
Principal Financial Group
Iowa
-$313K
5
GCP
GSA Capital Partners
United Kingdom
-$152K
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
51
Claro Advisors
Massachusetts
$9K +$10.4K +3 New
HR
52
Howe & Rusling
New York
$8K – – –
CL
53
CIM LLC
New York
$7K – – –
Bank of America
54
Bank of America
North Carolina
$7K +$3.48K +1 +50%
MC
55
Moors & Cabot
Massachusetts
$7K +$10.4K +3 New
IA
56
Inspire Advisors
Idaho
$6K – – –
GHAM
57
Gilman Hill Asset Management
Connecticut
$6K +$6.96K +2 New
Creative Planning
58
Creative Planning
Kansas
$5K -$20.9K -6 -75%
EWM
59
Empirical Wealth Management
Washington
$5K – – –
NWA
60
Navis Wealth Advisors
New York
$5K – – –
RWP
61
Ridgecrest Wealth Partners
California
$5K – – –
Koshinski Asset Management
62
Koshinski Asset Management
Illinois
$4.46K – – –
TRCT
63
Tower Research Capital (TRC)
New York
$4K +$6.96K +2 New
Credit Agricole
64
Credit Agricole
France
$3K – – –
DAC
65
Dividend Assets Capital
South Carolina
$3K – – –
IA
66
IFP Advisors
Florida
$3K – – –
Wells Fargo
67
Wells Fargo
California
$3K – – –
BG
68
Bollard Group
Massachusetts
$2K – – –
COCM
69
Charter Oak Capital Management
New Hampshire
$2K – – –
TWC
70
TD Waterhouse Canada
Ontario, Canada
$1.32K +$3.48K +1 New
CG
71
Cutler Group
California
$1K -$3.48K -1 Closed
HNWAG
72
High Net Worth Advisory Group
Florida
$1K – – –
National Bank of Canada
73
National Bank of Canada
Quebec, Canada
$1K – – –
WT
74
Washington Trust
Rhode Island
$1K – – –
KFS
75
Kelly Financial Services
Massachusetts
$822 – – –
1 2
3
4

TTOO Hedge Fund Activity: Q4 2021 in Review

70 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q4 2021, worth a combined $9.92M — down 53% from $21.1M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of TTOO and 9 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 15 added.

The largest buyer was Gagnon Securities, adding an estimated $170K. The largest seller was Goldman Sachs, cutting an estimated $1.74M.

  • 70 institutional investors held T2 Biosystems, Inc (TTOO) as of Q4 2021, down from 73 in Q3 2021.
  • Funds reported $9.92M of T2 Biosystems, Inc stock for Q4 2021, down 53% quarter-over-quarter.
  • 9 funds opened new T2 Biosystems, Inc positions in Q4 2021 and 12 closed out, a net change of -3 holders.
  • The largest T2 Biosystems, Inc buyer in Q4 2021 was Gagnon Securities, an estimated $170K added.
  • The largest T2 Biosystems, Inc seller in Q4 2021 was Goldman Sachs, an estimated $1.74M sold.

Based on aggregated 13F filings for Q4 2021.